Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics.
What is the anticipated market size of the losartan industry over the next few years?
The losartan market size has grown steadily in recent years. It will grow from $1.44 billion in 2024 to $1.50 billion in 2025 at a compound annual growth rate (CAGR) of 4.6%. The growth in the historic period can be attributed to the growing geriatric population, rising healthcare expenditure, rise in diabetic nephropathy cases, increasing awareness of blood pressure management, and growing adoption of generic ARBs.
The losartan market size is expected to see steady growth in the next few years. It will grow to $1.79 billion in 2029 at a compound annual growth rate (CAGR) of 4.6%. The growth in the forecast period can be attributed to increasing demand for cost-effective antihypertensive drugs, growing focus on preventive healthcare, rising prevalence of lifestyle-related disorders, expanding healthcare access in emerging markets, and continuous launch of generic formulations. Major trends in the forecast period include advancements in drug delivery systems, development of fixed-dose combination therapies, innovation in formulation technologies, advanced manufacturing processes, and development of personalized medicine approaches.
Download Your Free Sample PDF:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24284&type=smp
What emerging drivers are expected to shape the future of the losartan market?
The growing prevalence of hypertension is expected to propel the growth of the losartan market going forward. Hypertension is a condition marked by persistently high blood pressure, which can raise the likelihood of heart disease, stroke, and other severe health complications. The growing incidence of hypertension is linked to diets rich in salt and processed foods, which lead to fluid retention and increased heart strain. Losartan helps control hypertension by blocking angiotensin II, a hormone that narrows blood vessels. This helps relax and widen the vessels, lowering blood pressure and easing the heart’s workload. For instance, in January 2024, according to the American Heart Association, a US-based nonprofit organization, there were 131,454 deaths primarily linked to high blood pressure in 2022, an increase from 124,508 deaths in 2021. Therefore, the growing prevalence of hypertension is driving the growth of the losartan market.
What emerging segments are shaping the future landscape of the losartan industry?
The losartan market covered in this report is segmented –
1) By Dosage: Tablet, Powder, Suspension
2) By Source: Contract Manufacturing Organizations, In-House
3) By Distribution Channel: Online, Offline
4) By Application: Hypertension, Stroke, Diabetic Nephropathy, Other Applications
5) By End-User: Adult, Pediatric
Subsegments:
1) By Tablet: 25 Milligrams (mg), 50 Milligrams (mg), 100 Milligrams (mg)
2) By Powder: 25 Milligrams (mg), 50 Milligrams (mg), 100 Milligrams (mg)
3) By Suspension: 5 Milligrams (mg) Per 5 Milliliters (mL), 10 Milligrams (mg) Per 5 Milliliters (mL), 25 Milligrams (mg) Per 5 Milliliters (mL)
View The Full Market Report:
https://www.thebusinessresearchcompany.com/report/losartan-global-market-report
What are the top market trends driving innovation in the losartan industry?
Major companies operating in the losartan market are focusing on developing innovative products and getting approvals, such as losartan potassium oral suspension, to enhance patient compliance and expand therapeutic applications. Losartan potassium oral suspension is a liquid form of medication losartan potassium, intended for individuals who struggle with swallowing tablets. For instance, in March 2025, Scienture Holdings Inc., a US-based biopharmaceutical company, received Food and Drug Administration (FDA) approval for Arbli. It is a ready-to-use liquid formulation for hypertension, stroke risk reduction in hypertensive patients with left ventricular hypertrophy, and diabetic nephropathy in type 2 diabetes patients. It offers precise dosing without compounding and is available in a 165 mL peppermint-flavored suspension (10 mg/mL) with an 18-month shelf life at room temperature.
How are key players in the losartan market strengthening their market position?
Major companies operating in the losartan market are Viatris Inc., Teva Pharmaceutical Industries Ltd, Intas Pharmaceuticals Ltd., Sun Pharmaceutical Industries Ltd., Apotex Inc., Aurobindo Pharma Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Cadila Pharmaceuticals Ltd., Lupin Ltd., Zydus Lifesciences Ltd., Torrent Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd., Vasudha Pharma Chem Ltd., Unichem Laboratories Ltd., Global Pharma Tek, Manus Aktteva Biopharma LLP, Emcure Pharmaceuticals Ltd., Wellona Pharma, JPM Pharma & Chemicals Pvt. Ltd.
Which geographic areas are contributing significantly to the growth of the losartan sector?
North America was the largest region in the losartan market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the losartan market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
How Can Companies Use The Losartan Market Report to Drive Business Results?
This report provides actionable insights tailored for business use—not academic analysis. Companies can leverage the data to:
• Time market entry or expansion using growth forecasts and CAGR trends.
• Develop competitive products by tracking key technology shifts and user preferences.
• Tailor regional strategies with in-depth geographic data and local market dynamics.
• Benchmark and plan partnerships using competitive landscape insights.
Purchase The Report And Get A Swift Delivery:
https://www.thebusinessresearchcompany.com/customise?id=24284&type=smp
Need Customized Data On Losartan Market?
For companies needing more tailored intelligence, The Business Research Company offers customized consulting and data services. Whether you’re entering new regions, launching innovative products, or assessing M&A opportunities, our experts can develop actionable insights specific to your business objectives.
Request Customized Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24284&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
